Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    nct00667342
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Conditions: Osteosarcoma;   Malignant Fibrous Histiocytoma (MFH) of Bone
Interventions: Biological: Bevacizumab;   Drug: Cisplatin;   Drug: Doxorubicin;   Drug: Methotrexate;   Drug: Ifosfamide;   Drug: etoposide;   Procedure: Surgery;   Radiation: Radiotherapy

Study has passed its completion date and status has not been verified in more than two years.